198 related articles for article (PubMed ID: 34093540)
1. Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Encephalitis: A Review.
Zhang TY; Cai MT; Zheng Y; Lai QL; Shen CH; Qiao S; Zhang YX
Front Immunol; 2021; 12():652820. PubMed ID: 34093540
[TBL] [Abstract][Full Text] [Related]
2. Patient characteristics and outcome in patients with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis.
Lin J; Wang J; Li J
Neurol Sci; 2023 Sep; 44(9):3253-3259. PubMed ID: 37010671
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and prognosis of anti-alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor encephalitis.
Zhang Z; Fan S; Ren H; Zhou L; Guan H
BMC Neurol; 2021 Dec; 21(1):490. PubMed ID: 34915865
[TBL] [Abstract][Full Text] [Related]
4. Fulminant anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR1 antibodies encephalitis in a Chinese boy: a case report.
Han W; Ma J; Jiang L; Cheng M
BMC Pediatr; 2022 May; 22(1):287. PubMed ID: 35581601
[TBL] [Abstract][Full Text] [Related]
5. Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis developed after ovarian cancer cytoreduction surgery: a case report and literature review.
Huang Y; Zhou M; Zhou J; Wu B; Yang X; Min W; Li Z
BMC Womens Health; 2023 Sep; 23(1):507. PubMed ID: 37735388
[TBL] [Abstract][Full Text] [Related]
6. Fatal X-linked lymphoproliferative disease type 1-associated limbic encephalitis with positive anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antibody.
Ochiai S; Hayakawa I; Ohashi E; Hamano S; Miyata Y; Sakuma H; Hogetsu K; Gocho Y; Ogura M; Uchiyama T; Abe Y
Brain Dev; 2022 Oct; 44(9):630-634. PubMed ID: 35778314
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune Encephalitis With Multiple Auto-Antibodies With Concomitant Human Herpesvirus-7 and Ovarian Teratoma: A Case Report.
Yang J; Wu P; Liu X; Xia H; Lai Z
Front Med (Lausanne); 2021; 8():759559. PubMed ID: 35237615
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune Global Amnesia as Manifestation of AMPAR Encephalitis and Neuropathologic Findings.
Ricken G; Zrzavy T; Macher S; Altmann P; Troger J; Falk KK; Kiefer A; Fichtenbaum A; Mitulovic G; Kubista H; Wandinger KP; Rommer P; Bartsch T; Berger T; Weber J; Leypoldt F; Höftberger R
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34016735
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune Encephalitis with Antibodies Against A-Amino-3hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor and γ-Aminobutyric Acid-Beta Receptor: Case Report.
Doğan FU; Samanci B; Yilmaz V; Hanağasi HA; Gürvit İH; Tüzün E; Bilgiç B
Noro Psikiyatr Ars; 2024; 61(1):94-96. PubMed ID: 38496216
[TBL] [Abstract][Full Text] [Related]
10. Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies.
Guasp M; Landa J; Martinez-Hernandez E; Sabater L; Iizuka T; Simabukuro M; Nakamura M; Kinoshita M; Kurihara M; Kaida K; Bruna J; Kapetanovic S; Sánchez P; Ruiz-García R; Naranjo L; Planagumà J; Muñoz-Lopetegi A; Bataller L; Saiz A; Dalmau J; Graus F
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34301822
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric lupus erythematosus with neurogenic pulmonary edema and anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor limbic encephalitis: a case report.
Li R; Wang Y; Wu X; Wang J; Wei W; Li X
BMC Neurol; 2022 Jun; 22(1):222. PubMed ID: 35710378
[TBL] [Abstract][Full Text] [Related]
12. Clinical Character of CASPR2 Autoimmune Encephalitis: A Multiple Center Retrospective Study.
Qin X; Yang H; Zhu F; Wang Q; Shan W
Front Immunol; 2021; 12():652864. PubMed ID: 34054814
[TBL] [Abstract][Full Text] [Related]
13. Case report: Seropositive myasthenia gravis complicated by limbic encephalitis positive for antibodies to AMPAR and Lgi1.
Nes MS; Haugen M; Haugland HK; Gilhus NE; Vedeler CA
Front Neurol; 2023; 14():1237140. PubMed ID: 37900608
[TBL] [Abstract][Full Text] [Related]
14. Status epilepticus suspected autoimmune: Neuronal surface antibodies and main clinical features.
Suga H; Yanagida A; Kanazawa N; Ohara H; Kitagawa T; Hayashi M; Onozawa Y; Nagata N; Kaneko J; Kitamura E; Nishiyama K; Iizuka T
Epilepsia; 2021 Nov; 62(11):2719-2731. PubMed ID: 34462918
[TBL] [Abstract][Full Text] [Related]
15. Thymoma-associated autoimmune encephalitis: Analysis of factors determining prognosis.
Song W; Li K; Li J; Liu X; Wu X; Xu X; Xiong K; Chen X; Zhang Y
CNS Neurosci Ther; 2023 May; 29(5):1213-1221. PubMed ID: 36914970
[TBL] [Abstract][Full Text] [Related]
16. Clinical Review and Prognostic Analysis of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionate Receptor-Associated Encephalitis.
Wang K; Shi Y; Du Q; Zhang RR; Wu H; Qiao S; Liu X
Front Neurol; 2021; 12():665229. PubMed ID: 34054708
[No Abstract] [Full Text] [Related]
17. Case report: Autoimmune encephalitis associated with anti-CASPR2 antibody mimicking cerebral infarction.
Chen Z; Tang J
Front Immunol; 2023; 14():1041664. PubMed ID: 36776888
[TBL] [Abstract][Full Text] [Related]
18. AMPAR autoimmunity: Neurological and oncological accompaniments and co-existing neural autoantibodies.
McCombe JA; Zivelonghi C; Vorasoot N; Majed M; Flanagan EP; Dubey D; Pittock SJ; McKeon A; Zekeridou A
J Neuroimmunol; 2023 Feb; 375():578012. PubMed ID: 36608398
[TBL] [Abstract][Full Text] [Related]
19. Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease.
Song Y; Chen S; Gao J; Lu J; Xu W; Lin X; Chen J
Front Neurol; 2021; 12():673347. PubMed ID: 34276536
[TBL] [Abstract][Full Text] [Related]
20. Management of Autoimmune Encephalitis in a 7-Year-Old Child With CTLA-4 Haploinsufficiency and AMPA Receptor Antibodies: A Case Report.
Quaak MSW; Buijze MSJS; Verhoeven VJM; Vermont C; Buddingh EP; Heredia M; Samsom JN; Titulaer MJ; van Rossum AM; Kamphuis S; Neuteboom RF
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200254. PubMed ID: 38728609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
